Literature DB >> 35934951

Morphoea and COVID-19 vaccination.

Pathum Sookaromdee1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35934951      PMCID: PMC9538876          DOI: 10.1111/ced.15365

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   4.481


× No keyword cloud information.
Dear Editor We read with interest the recent article in Clinical and Experimental Dermatology by Oh et al., who reported a case of morphoea with a possible clinical link to the COVID‐19 vaccine. We agree with the authors that the COVID‐19 vaccine may cause clinical issues, and morphoea may have negative effects. However, we consider it unclear that the reported case is related to vaccination. It is challenging to draw conclusions from this paper because there was no prevaccination information on the vaccine recipient's immunological, skin or health status. The vaccine recipient may have morphoea as a comorbidity, which is occasionally overlooked and might be misinterpreted as a negative outcome of the vaccine.
  1 in total

1.  Comment on 'Morphoea following COVID-19 vaccination'.

Authors:  Fabrizio Martora; Teresa Battista; Angelo Ruggiero; Gabriella Fabbrocini; Luca Potestio
Journal:  Clin Exp Dermatol       Date:  2022-09-02       Impact factor: 4.481

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.